Unraveling Cancer

Join us for the Unraveling Cancer Podcast Series where we explore stories and news about living with cancer, the latest research from conferences, and patient advocate stories. Our patient hosts are joined by leaders in the field; from researchers working on the treatments of tomorrow, to holistic practitioners and mental health professionals. Patient Power® is a leader in supporting patients with cancer and caregivers in their treatment journey; interviewing top medical experts and researchers to offer the latest findings and information, as well as personal accounts from dedicated advocates, patients, and care partners. We are committed to helping each person approach their illness in a way that gives them the best chance of regaining and maintaining good health – from fully understanding their individual diagnosis, to seeking the best care, to getting second or third opinions, to consider a clinical trial. Find us at https://www.patientpower.info/

Unraveling Cancer is a health podcast hosted by Patient Power, with 19 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Patient Power hosts Unraveling Cancer, a health show with 19 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #20

  Your Guide to Starting and Stopping CLL Treatment

  May 28, 202621 minS0

  <p>As a 16-year CLL patient himself, Brad brings a personal perspective as Dr. Rogers explains<br> what fixed duration treatment means, which drug combinations are currently approved, and<br> what the ramp-up process looks like, including why close monitoring is required in the early<br> weeks. They discuss how treatment length is determined, what ongoing monitoring looks like,<br> and how side effects typically resolve once treatment ends. Dr. Rogers also breaks down how<br> factors like disease genetics, other health conditions, lifestyle, and personal preference all play<br> a role in deciding whether fixed duration or continuous therapy...

  ListenShow Notes
• 

  Episode #19

  Fixed vs. Continuous CLL Treatment Explained

  Apr 28, 202630 minS0

  <p>In this episode of the Patient Power podcast, Unraveling Cancer, patient host Brad<br> Adams is joined by Paul J. Hampel, MD, a hematologist-oncologist at Mayo Clinic in Rochester,<br> for a conversation about fixed duration versus continuous treatment for chronic lymphocytic<br> leukemia (CLL), including benefits, side effects, monitoring, and how to choose the best option<br> based on your lifestyle and disease features.</p>

  ListenShow Notes
• 

  Episode #18

  New Immune Advances in CLL

  Mar 26, 202624 minS0

  <p>In this episode of the Patient Power podcast, Unraveling Cancer, patient host Michele Nadeem-Baker is joined by Thomas Kipps, MD, PhD, UC San Diego, for a conversation about the latest immune-based advances in chronic lymphocytic leukemia (CLL), including targeted therapies, CAR T-cell treatment, vaccines, and infection prevention. Learn how new research is improving outcomes and bringing hope for a future cure.</p>

  ListenShow Notes
• 

  Episode #17

  Is Fixed Duration Therapy the New Standard?

  Nov 19, 202525 minS0

  <p>Patient advocate, Michele Nadeem Baker, hosts Boyu Hu, MD, Director of Lymphoma and Chronic Lymphocytic Leukemia at the Huntsman Cancer Institute at the University of Utah for a discussion on fixed duration treatment.</p>

  ListenShow Notes
• 

  Episode #16

  From Diagnosis to Treatment End: Navigating Fixed-Duration Therapy for CLL

  Oct 30, 202533 minS0

  <p>Physician assistant Jill Miller shares what CLL patients really need to know about fixed-duration treatment. Learn how to manage side effects, what to expect month by month, when treatment ends, and how to navigate the emotional transition from active therapy to surveillance.</p>

  ListenShow Notes

Recent guests on Unraveling Cancer. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.